Search Within

Peter Maslak

  1. "Biostatistics Service"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (11)
  3. Conference Paper (1)
Groups
  1. Adult Leukemia (28)
  2. Biostatistics Service (28)
  3. Center for Hematologic Malignancies (28)
  4. Department of Medicine (28)
  5. Epidemiology and Biostatistics (28)
  6. Hematologic Malignancies, Division of (28)

More Groups

People
  1. Sean Devlin (11)
  2. David Scheinberg (10)
  3. Renier Brentjens (9)
  4. Joseph Jurcic (8)
  5. Katherine Panageas (8)
  6. Sergio Giralt (8)

More People

Years
  1. 2022 (1)
  2. 2021 (3)
  3. 2020 (1)
  4. 2019 (1)
  5. 2018 (3)
  6. 2014 (2)

More Years

Publications
  1. Blood (9)
  2. Journal of Clinical Oncology (4)
  3. Biology of Blood and Marrow Transplantation (2)
  4. Leukemia (2)
  5. Bone Marrow Transplantation (1)
  6. Cancer (1)

More Publications

Publishers
  1. American Society of Hematology (9)
  2. American Society of Clinical Oncology (4)
  3. Elsevier Inc. (4)
  4. Nature Publishing Group (3)
  5. American Association for Cancer Research (1)
  6. American Association for the Advancement of Science (1)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Validation of flow cytometric measurements of NK cytotoxicity against chromium release assay for use in clinical monitoring of immune function
    Meeting Abstract

    Smith, K.; Heller, G.; Maslak, P.
    Blood (2006)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia
    Journal Article

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J. G.; Heaney, M.; Brentjens, R.; Zelenetz, A. D.; Horgan, D.; Gencarelli, A.; Panageas, K. S.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • A randomized trial of cytarabine with high-dose mitoxantrone compared to a standard vincristine/prednisone-based regimen as induction therapy for adult patients with ALL
    Meeting Abstract

    Weiss, M. A.; Heffner, L.; Lamanna, N.; Kalaycio, M.; Schiller, G.; Coutre, S.; Maslak, P.; Jurcic, J.; Panageas, K.; Scheinberg, D. A.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, and rituximab (PCR) has comparable activity but appears to be better tolerated than fludarabine, cyclophosphamide, and rituximab (FCR) in patients with previously treated chronic lymphocytic leukemia
    Meeting Abstract

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Heaney, M. L.; Brentjens, R.; Jurcic, J.; Biederman, E.; Gencarelli, A. N.; Panageas, K. S.; Scheinberg, D. A.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Treatment of acute promyelocytic leukemia with all-trans retinoic acid: An update of the New York experience
    Conference Paper

    Warrell, R. P. Jr; Maslak, P.; Eardley, A.; Heller, G.; Miller, W. H. Jr; Frankel, S. R.
    Nature Publishing Group (1994)

    Fulltext@MSK | Save
  • Treatment of acute promyelocytic leukemia with all-trans retinoic acid: An update of the New York experience
    Journal Article

    Warrell, R. P. Jr; Maslak, P.; Eardley, A.; Heller, G.; Miller, W. H. Jr; Frankel, S. R.
    Leukemia (1994)

    Fulltext@MSK | Save
  • Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PMN/RAR-α isoform, and CD13 expression in patients treated with all-trans retinoic acid
    Journal Article

    Vahdat, L.; Maslak, P.; Miller, W. H. Jr; Eardley, A.; Heller, G.; Scheinberg, D. A.; Warrell, R. P. Jr
    Blood (1994)

    Fulltext@MSK | Save
  • CD2 expression and PML/RAR-α transcripts in acute promyelocytic leukemia
    Journal Article

    Maslak, P.; Miller, W. H. Jr; Heller, G.; Scheinberg, D. A.; Dmitrovsky, E.; Warrell, R. P. Jr
    Blood (1993)

    Fulltext@MSK | Save